Il‐Chi Chang

575 total citations
18 papers, 428 citations indexed

About

Il‐Chi Chang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Ecology. According to data from OpenAlex, Il‐Chi Chang has authored 18 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Ecology. Recurrent topics in Il‐Chi Chang's work include Physiological and biochemical adaptations (4 papers), Hepatitis B Virus Studies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Il‐Chi Chang is often cited by papers focused on Physiological and biochemical adaptations (4 papers), Hepatitis B Virus Studies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Il‐Chi Chang collaborates with scholars based in Taiwan, United States and India. Il‐Chi Chang's co-authors include Pung‐Pung Hwang, Fong‐In Chou, Tsung‐Han Lee, Ya‐Ting Chen, Shiu-Feng Huang, Yi‐Rong Chen, Yen Chu, Yi‐Cheng Wu, Huiping Liu and Tai‐Di Chen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Il‐Chi Chang

18 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Il‐Chi Chang Taiwan 12 145 144 114 111 103 18 428
Zhenguo Qiao China 12 121 0.8× 115 0.8× 31 0.3× 35 0.3× 100 1.0× 62 406
Yosuke Amano Japan 14 136 0.9× 182 1.3× 101 0.9× 133 1.2× 22 0.2× 47 549
Jintao Guo China 13 45 0.3× 210 1.5× 81 0.7× 108 1.0× 100 1.0× 41 512
Y Takahashi Japan 7 43 0.3× 152 1.1× 79 0.7× 46 0.4× 23 0.2× 10 412
K T Huynh United States 5 63 0.4× 110 0.8× 204 1.8× 66 0.6× 17 0.2× 5 405
Jiexia Quan United States 11 57 0.4× 192 1.3× 37 0.3× 23 0.2× 22 0.2× 22 509
Graham Young Australia 12 82 0.6× 79 0.5× 62 0.5× 26 0.2× 113 1.1× 22 518
Ioanna Giopanou Greece 13 19 0.1× 219 1.5× 151 1.3× 123 1.1× 18 0.2× 23 528
A. R. Gibbs United Kingdom 11 35 0.2× 91 0.6× 81 0.7× 243 2.2× 44 0.4× 17 518
Michael J. Domanico United States 10 33 0.2× 212 1.5× 451 4.0× 241 2.2× 28 0.3× 16 740

Countries citing papers authored by Il‐Chi Chang

Since Specialization
Citations

This map shows the geographic impact of Il‐Chi Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Il‐Chi Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Il‐Chi Chang more than expected).

Fields of papers citing papers by Il‐Chi Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Il‐Chi Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Il‐Chi Chang. The network helps show where Il‐Chi Chang may publish in the future.

Co-authorship network of co-authors of Il‐Chi Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Il‐Chi Chang. A scholar is included among the top collaborators of Il‐Chi Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Il‐Chi Chang. Il‐Chi Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Yuting, Il‐Chi Chang, Chih‐Yi Chen, et al.. (2023). Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma. Thoracic Cancer. 14(6). 592–601. 2 indexed citations
2.
Chen, Ya‐Ting, et al.. (2022). CA10 is associated with HBV-related hepatocarcinogenesis. Biochemistry and Biophysics Reports. 31. 101303–101303. 2 indexed citations
3.
Huang, Shiu‐Feng, Il‐Chi Chang, Pei‐Jer Chen, et al.. (2019). AB032. S7-3. Introduction of Taiwan Liver Cancer Network. HepatoBiliary Surgery and Nutrition. 8(S1). AB032–AB032. 1 indexed citations
4.
Huang, Shiu‐Feng, Il‐Chi Chang, Tseng‐Chang Yen, et al.. (2018). Metabolic risk factors are associated with non‐hepatitis B non‐hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B. Hepatology Communications. 2(6). 747–759. 34 indexed citations
5.
Huang, Shih‐Chiang, Shiu‐Feng Huang, Ya‐Ting Chen, et al.. (2017). Overexpression of MutL homolog 1 and MutS homolog 2 proteins have reversed prognostic implications for stage I–II colon cancer patients. Biomedical Journal. 40(1). 39–48. 14 indexed citations
6.
Cheng, An Ning, Chi‐Chen Fan, Cheng‐Liang Kuo, et al.. (2017). Cdc7-Dbf4-mediated phosphorylation of HSP90-S164 stabilizes HSP90-HCLK2-MRN complex to enhance ATR/ATM signaling that overcomes replication stress in cancer. Scientific Reports. 7(1). 17024–17024. 22 indexed citations
7.
Huang, Shiu‐Feng, Hong‐Dar Isaac Wu, Ya‐Ting Chen, et al.. (2016). Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma. Tumor Biology. 37(7). 9745–9753. 14 indexed citations
8.
Jiang, Shih Sheng, Shiu‐Feng Huang, Yng‐Tay Chen, et al.. (2014). Dysregulation of the TGFBI gene is involved in the oncogenic activity of the nonsense mutation of hepatitis B virus surface gene sW182*. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(7). 1080–1087. 5 indexed citations
9.
10.
Huang, Shiu-Feng, Ya‐Ting Chen, Wei‐Chen Lee, et al.. (2014). Identification of Transforming Hepatitis B Virus S Gene Nonsense Mutations Derived from Freely Replicative Viruses in Hepatocellular Carcinoma. PLoS ONE. 9(2). e89753–e89753. 19 indexed citations
11.
Wu, Yi‐Cheng, Il‐Chi Chang, Tai‐Di Chen, et al.. (2013). Comparison of IHC, FISH and RT-PCR Methods for Detection of ALK Rearrangements in 312 Non-Small Cell Lung Cancer Patients in Taiwan. PLoS ONE. 8(8). e70839–e70839. 93 indexed citations
12.
Ho, Yen‐Chun, Il‐Chi Chang, Kathrin H. Kirsch, et al.. (2013). Cysteine-rich protein 2 alters p130Cas localization and inhibits vascular smooth muscle cell migration. Cardiovascular Research. 100(3). 461–471. 23 indexed citations
13.
Huang, Shiu‐Feng, Tai‐Di Chen, Il‐Chi Chang, et al.. (2012). Correlation of anaplastic lymphoma kinase overexpression and the EML4-ALK fusion gene in non-small cell lung cancer by immunohistochemical study. Biomedical Journal. 35(4). 309–309. 5 indexed citations
14.
Lin, Dawei, Il‐Chi Chang, Alan Tseng, et al.. (2008). Transforming Growth Factor β Up-regulates Cysteine-rich Protein 2 in Vascular Smooth Muscle Cells via Activating Transcription Factor 2. Journal of Biological Chemistry. 283(22). 15003–15014. 31 indexed citations
15.
Tang, Cheng‐Hao, et al.. (2008). Phenotypic Changes in Mitochondrion-Rich Cells and Responses of Na+/K+-ATPase in Gills of Tilapia Exposed to Deionized Water. ZOOLOGICAL SCIENCE. 25(2). 205–211. 18 indexed citations
16.
Chang, Il‐Chi & Pung‐Pung Hwang. (2004). Cl−Uptake Mechanism in Freshwater‐Adapted Tilapia (Oreochromis mossambicus). Physiological and Biochemical Zoology. 77(3). 406–414. 36 indexed citations
17.
Chang, Il‐Chi, et al.. (2003). Stimulation of Cl−Uptake and Morphological Changes in Gill Mitochondria‐Rich Cells in Freshwater Tilapia (Oreochromis mossambicus). Physiological and Biochemical Zoology. 76(4). 544–552. 35 indexed citations
18.
Chang, Il‐Chi, et al.. (2001). Morphology and Function of Gill Mitochondria‐Rich Cells in Fish Acclimated to Different Environments. Physiological and Biochemical Zoology. 74(1). 111–119. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenguo Qiao Breakdown of academic impact, for papers by Yosuke Amano Breakdown of academic impact, for papers by Jintao Guo Breakdown of academic impact, for papers by Y Takahashi Breakdown of academic impact, for papers by K T Huynh Breakdown of academic impact, for papers by Jiexia Quan Breakdown of academic impact, for papers by Graham Young Breakdown of academic impact, for papers by Ioanna Giopanou Breakdown of academic impact, for papers by A. R. Gibbs Breakdown of academic impact, for papers by Michael J. Domanico
Rankless by CCL
2026